The US Food and Drug Administration (FDA) recommended that the FDA should issue warnings to doctors and patients about drug eluting coronary stents. The safety of such stents is unclear except in low risk patients. Furthermore, patients with drug eluting stents should take antiplatelet therapy for at least one year after insertion
According to the report, The reimbursement coverage along with a high incidence rate of artery diseases is one of the primary growth factors for the market. The rising geriatric population worldwide
is also expected to contribute significantly to the Drug Eluting Stents market growth. Overall, Coronary Artery Disease
applications of Drug Eluting Stents, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Drug Coating, such as Polymer-based Coatings, is boosting the Drug Eluting Stents market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The End user, such as Hospitals, is boosting the Drug Eluting Stents market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
AMA’s Analyst on the Global Drug Eluting Stents market identified that the demand is rising in many different parts of the world as "Increasing demand from emerging economies". Furthermore, some recent industry insights like "In August 2022,Medtronic announced today that it has launched its newest drug-eluting coronary stent, the Onyx Frontier™ drug-eluting stent (DES), following recent CE Mark approval. The Onyx Frontier DES offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent." is constantly making the industry dynamic.
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global Drug Eluting Stents market according to Type, Application, and regions o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders’ insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2022 currency rates.
Market Size Estimation In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Drug Eluting Stents market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research. o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes. o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation The overall Drug Eluting Stents market size is calculated using market estimation process, the Drug Eluting Stents market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Drug Eluting Stents market size has been validated using both top-down and bottom-up approaches.